Processa Pharmaceuticals Long Term Deferred Assets (Quarterly) Analysis

Processa Pharmaceuticals, Inc. (PCSA)

2.10 -0.18 (-7.89%) USD | NASDAQ | Feb 20, 16:00

2.00 -0.10 (-4.76%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for PCSA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Kodiak Sciences, Inc.	--
Pyxis Oncology, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	--